Related Articles
Quinalizarin, a specific CK2 inhibitor, can reduce icotinib resistance in human lung adenocarcinoma cell lines
In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell lines
Correlation of EGFR Del 19 with Fn14/JAK/STAT signaling molecules in non-small cell lung cancer
MEK1 gene mutation in Japanese lung adenocarcinoma patients
Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation